Retraction: Effect of atorvastatin on resolution of chronic subdural hematoma: a prospective observational study

  • Liu H
N/ACitations
Citations of this article
36Readers
Mendeley users who have this article in their library.

Abstract

OBJECTIVE Chronic subdural hematoma (CSDH) is prevalent in the aged population and is commonly treated with bur hole drainage. This treatment, however, can lead to various surgical complications. Atorvastatin may cure CSDH via its antiinflammatory and proangiogenesis effects, but not all patients treated with this medication can avoid surgery. The authors' aim was to investigate the effect of atorvastatin and identify characteristics of patients with CSDH sensitive to atorvastatin therapy. METHODS A prospective, placebo-controlled observational study was conducted in 80 patients with evidence of CSDH. The patients were enrolled between February 2012 and August 2014 and were randomly assigned to either atorvastatin treatment (atorvastatin group) or placebo (control group). Patients were followed up for 12 months after initiation of treatment. Clinically relevant data were collected and compared between the 2 groups. The atorvastatin group was subdivided into patients who required surgery and those who did ...

Cite

CITATION STYLE

APA

Liu, H. (2016). Retraction: Effect of atorvastatin on resolution of chronic subdural hematoma: a prospective observational study. Journal of Neurosurgery, 126(2), 651. https://doi.org/10.3171/2016.10.jns151991r

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free